Human fibroblast-derived dermal substitute: results from a treatment investigational device exemption (TIDE) study in diabetic foot ulcers.

Advances in skin & wound care

Volumn 24, Issue 7, 2011, Pages 306-311

  Warriner 3rd , Robert A ^a   Cardinal, Matthew ^b   TIDE Investigators, ^b  

^a Diversified Clinical Services   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFICIAL SKIN; CLINICAL TRIAL; DIABETIC FOOT; FEMALE; FIBROBLAST; FOOT ULCER; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; NONPARAMETRIC TEST; PILOT STUDY; PROSPECTIVE STUDY; STATISTICAL MODEL;

DIABETIC FOOT; FEMALE; FIBROBLASTS; FOOT ULCER; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; SKIN, ARTIFICIAL; STATISTICS, NONPARAMETRIC;

EID: 82255179890     PISSN: None     EISSN: 15388654     Source Type: Journal    
DOI: None     Document Type: Article

References (0)